These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 75861
1. A new passive anterior rhinometric method for clinical study of nasal decongestant. Cho YW. Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):63-7. PubMed ID: 75861 [No Abstract] [Full Text] [Related]
3. How we do it: "The oral tube area method": a new method for self-assessment of nasal resistance. Pontoppidan JM. Clin Otolaryngol; 2005 Dec; 30(6):557-60. PubMed ID: 16402985 [Abstract] [Full Text] [Related]
7. Nasal decongestant activity of pseudoephedrine. Roth RP, Cantekin EI, Bluestone CD, Welch RM, Cho YW. Ann Otol Rhinol Laryngol; 1977 Aug; 86(2 pt. 1):235-42. PubMed ID: 322570 [Abstract] [Full Text] [Related]
8. [Rhinomanometric tests of the effect of nasivinettes in normal subjects (author's transl)]. Ey W, Skevas A. Laryngol Rhinol Otol (Stuttg); 1974 Mar; 53(5):352-7. PubMed ID: 4136431 [No Abstract] [Full Text] [Related]
9. Rhinomanometry. III. Procedures and criteria for distinction between skeletal stenosis and mucosal swelling. Broms P. Acta Otolaryngol; 1982 Mar; 94(3-4):361-70. PubMed ID: 6183919 [Abstract] [Full Text] [Related]
10. The relationship between nasal index and nasal airway resistance, and response to a topical decongestant. Doddi NM, Eccles R. Rhinology; 2011 Dec; 49(5):583-6. PubMed ID: 22125790 [Abstract] [Full Text] [Related]
11. The determination of the optimal oral dose of pseudoephedrine for nasal decongestion using nasal histamine challenge and anterior rhinometry [proceedings]. Bagg LR, Empey DW, Hughes DT, John GC, Letley E, Young GA. Br J Clin Pharmacol; 1979 Apr; 7(4):426P. PubMed ID: 87212 [No Abstract] [Full Text] [Related]
12. [The effect of nasal dilators and local decongestants on the nasal airway]. Akçam T, Karakoç O, Karahatay S, Yetişer S. Kulak Burun Bogaz Ihtis Derg; 2005 Apr; 15(5-6):97-102. PubMed ID: 16444089 [Abstract] [Full Text] [Related]
13. Nasal airflow asymmetry and the effects of a topical nasal decongestant. Williams RG, Eccles R. Rhinology; 1992 Dec; 30(4):277-82. PubMed ID: 1281924 [Abstract] [Full Text] [Related]
14. [The rebound of nasal resistance after decongestant used in nose]. Shen J, Huang X, Xiang J, Shu H. Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428 [Abstract] [Full Text] [Related]
15. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine. Bende M, Andersson KE, Johansson CJ, Sjögren C, Svensson G. Acta Otolaryngol; 1984 Dec; 98(5-6):543-7. PubMed ID: 6084394 [Abstract] [Full Text] [Related]
16. A system of rhinomanometry in the clinical evaluation of nasal decongestants. Dressler WE, Myers T, Rankell AS, London SJ, Poetsch CE. Ann Otol Rhinol Laryngol; 1977 Dec; 86(3 Pt 1):310-7. PubMed ID: 68703 [Abstract] [Full Text] [Related]
17. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. Castellano F, Mautone G. Drugs Exp Clin Res; 2002 Dec; 28(1):27-35. PubMed ID: 12073765 [Abstract] [Full Text] [Related]